RIGEL PHARMACEUTICALS INC — Director's Dealing 2020

May 16, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2020-05-14

Reporting Person: Cabatuan Nelson (VP,Finance & Princ.Acctg. Off.)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-14	Stock Option (Right to Buy)	$1.75	A	20000	Acquired	2030-05-14	Common Stock (20000)	Direct

Footnotes

F1: Fifty per cent (50%) of the shares subject to the option shall vest one year from the date of grant and fifty per cent (50%) of the shares subject to the option shall vest shall vest two years from the date of grant, subject to the reporting person's continuous service to the issuer through each such period.